Literature DB >> 10630489

Inhibition by 16,16-dimethyl prostaglandin E2 of tumor necrosis factor-alpha and interleukin-1beta production and messenger RNA expression in human monocytes stimulated by Helicobacter pylori.

O Takaishi1, T Arakawa, Y Fujiwara, T Fukuda, K Otani, K Yamasaki, K Higuchi, T Kuroki.   

Abstract

We investigated the effects of 16,16-dimethyl prostaglandin E2 on the production of tumor necrosis factor-alpha and interleukin-1beta in human monocytes stimulated with Helicobacter pylori. Monocytes isolated from human peripheral blood were incubated for 24 hr with the extract of H. pylori diluted 1:100 to 1:100,000 by volume, a combination of the extract and 16,16-dimethyl prostaglandin E2, or a vehicle alone. The extract stimulated the production of tumor necrosis factor-alpha and interleukin-1beta and the expression of their messenger RNA in a dose-dependent manner. 16,16-Dimethyl prostaglandin E2 inhibited the production of these cytokines and their messenger RNA in the presence of H. pylori at doses higher than 10(-6) M, predominantly with tumor necrosis factor-alpha. These data suggest that antiinflammatory effects of prostaglandins on gastric mucosa are in part related to their effects on inhibition of production of proinflammatory cytokines by monocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10630489     DOI: 10.1023/a:1026614400820

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  40 in total

1.  Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production.

Authors:  P R Harris; H L Mobley; G I Perez-Perez; M J Blaser; P D Smith
Journal:  Gastroenterology       Date:  1996-08       Impact factor: 22.682

2.  Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa.

Authors:  Y Yamaoka; M Kita; T Kodama; N Sawai; J Imanishi
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

Review 3.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

4.  Helicobacter pylori water extract induces interleukin-8 production by gastric epithelial cells.

Authors:  K Kassai; T Yoshikawa; N Yoshida; A Hashiramoto; M Kondo; H Murase
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

5.  Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism.

Authors:  U E Mai; G I Perez-Perez; L M Wahl; S M Wahl; M J Blaser; P D Smith
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

Review 6.  Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation.

Authors:  M J Blaser
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

7.  Prostaglandin E2 stimulates osteoclast formation via endogenous IL-1 beta expressed through protein kinase A.

Authors:  S Amano; K Naganuma; Y Kawata; K Kawakami; S Kitano; S Hanazawa
Journal:  J Immunol       Date:  1996-03-01       Impact factor: 5.422

Review 8.  Prostaglandins, NSAIDs, and cytoprotection.

Authors:  J L Wallace
Journal:  Gastroenterol Clin North Am       Date:  1992-09       Impact factor: 3.806

9.  Regulation of macrophage tumor necrosis factor production by prostaglandin E2.

Authors:  S L Kunkel; R C Wiggins; S W Chensue; J Larrick
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

10.  Mechanisms involved in Helicobacter pylori-induced inflammation.

Authors:  N Yoshida; D N Granger; D J Evans; D G Evans; D Y Graham; D C Anderson; R E Wolf; P R Kvietys
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

View more
  3 in total

Review 1.  15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications.

Authors:  Tetsuo Arakawa; Kazuhide Higuchi; Yasuhiro Fujiwara; Toshio Watanabe; Kazunari Tominaga; Eiji Sasaki; Nobuhide Oshitani; Toshikazu Yoshikawa; Andrzej S Tarnawski
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

2.  NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations.

Authors:  Leanne Mortimer; France Moreau; Justin A MacDonald; Kris Chadee
Journal:  Nat Immunol       Date:  2016-08-22       Impact factor: 25.606

3.  Involvement of cyclooxygenase-2--prostaglandin E2 pathway in interleukin-8 production in gastric cancer cells.

Authors:  Hisashi Takehara; Junichi Iwamoto; Jun-Ichi Iwamoto; Yuji Mizokami; Kimiko Takahashi; Toshiya Ootubo; Syuuhei Miura; Toshiaki Narasaka; Hiroki Takeyama; Takayuki Omata; Koichi Shimokobe; Masanori Ito; Takeshi Matsuoka
Journal:  Dig Dis Sci       Date:  2006-11-01       Impact factor: 3.487

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.